Atropine Dosing for Organophosphorus Poisoning
For life-threatening organophosphate poisoning, administer atropine immediately with an initial dose that is doubled every 5 minutes until full atropinization is achieved (clear chest on auscultation, heart rate >80/min, systolic blood pressure >80 mm Hg), then maintain with continuous infusion. 1
Initial Dosing Strategy
Adults
- Start with 2-3 mg IV as initial bolus for severe poisoning with bronchospasm, bronchorrhea, seizures, or significant bradycardia 2
- Double the dose every 5 minutes until atropinization endpoints are reached 1, 3
- Much larger doses than typical bradycardia treatment are required—patients may need 23-75 mg or more in the first hours 4, 5
- The FDA label recommends 2-3 mg initially, repeated every 20-30 minutes as needed 2
Pediatric Patients
- Initial dose: 20-50 mg/kg (not the typical 0.01-0.03 mg/kg used for other indications) 1
- Apply the same doubling strategy every 5 minutes until atropinization 3
- For children >1 year with nerve agent exposure, full adult autoinjector doses (2 mg from Mark 1 kit) are appropriate when precise dosing is impossible 6
Atropinization Endpoints
Achieve all three of the following before reducing dosing 1:
- Clear chest on auscultation (resolution of bronchorrhea and bronchospasm)
- Heart rate >80 beats/min
- Systolic blood pressure >80 mm Hg
Maintenance Therapy
- Continuous infusion at 10-20% of the loading dose per hour once atropinization is achieved 1
- Typical maintenance ranges from 0.005-0.06 mg/kg/h depending on severity of acetylcholinesterase inhibition 7
- When RBC-AChE activity is 10-30% of normal, approximately 0.005 mg/kg/h maintains therapeutic levels 7
- When RBC-AChE is completely inhibited, doses up to 0.06 mg/kg/h may be required 7
Critical Implementation Points
Rapid Escalation is Essential
- Modern guidelines emphasize aggressive, rapid atropinization compared to older regimens that took hours to days 4
- Current evidence-based regimens can achieve adequate atropinization within 30-60 minutes, compared to historical approaches requiring 18+ hours 4
- Early atropine administration improves survival in clinical trials of life-threatening organophosphate poisoning 1, 3
Common Pitfalls to Avoid
Do not underdose atropine 4, 5:
- The most common error is using doses appropriate for typical bradycardia rather than the supraphysiologic doses required for cholinergic crisis 3
- Some patients require cumulative doses exceeding 100 mg in the first 6 hours 8
Monitor for inadequate response 8:
- If target heart rate is not achieved despite 100 mg cumulative dose in 6 hours or 30 mg/h infusion for 3 hours, consider adding adrenaline infusion at 2-4 μg/min 8
- Inadequate response is associated with shorter time to hospital presentation and requires longer ventilation duration 8
Watch for late complications 7:
- Malignant arrhythmias can occur when S-hyoscyamine concentrations fall below 2.5 nmol/L, often in the absence of obvious cholinergic signs 7
- These typically resolve with reinstitution of atropine 7
Adjunctive Therapy
Pralidoxime (Oximes)
- Reasonable to administer for organophosphate poisoning (Class 2a recommendation) 1
- Adults: 1-2 g loading dose, then 400-600 mg/h continuous infusion 1
- Pediatric: 20-50 mg/kg loading dose, then 10-20 mg/kg/h infusion 1
- Must be given early before "aging" of the organophosphate-enzyme complex occurs 1
- Clinical efficacy remains uncertain in meta-analyses, with no mortality benefit demonstrated and possible increased incidence of intermediate syndrome 9
Other Essential Interventions
- Benzodiazepines (diazepam first-line or midazolam) for seizures and agitation (Class 1 recommendation) 1
- Early endotracheal intubation for life-threatening poisoning improves outcomes (Class 1 recommendation) 1, 3
- Dermal decontamination with removal of clothing and copious soap/water irrigation (Class 1 recommendation) 1, 3
- Personal protective equipment for healthcare workers to prevent secondary contamination (Class 1 recommendation) 1
Special Considerations
Coronary Artery Disease
- Limit total atropine dose to 0.03-0.04 mg/kg in patients with known coronary disease to minimize risk of myocardial ischemia 2
- This creates a clinical dilemma requiring careful risk-benefit assessment in severe poisoning
Atropine Tolerance
- Atropine overdose is generally well tolerated in children, supporting the use of higher doses when needed 6
- The elimination half-life of S-hyoscyamine is approximately 1.5 hours, with occasional secondary slow phase of 12 hours 7